Journal article : Review
Immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies
- Abstract:
-
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. This protocol is for two separate reviews to assess the effects (benefits and harms) of immunosuppressant and immunomodulatory treatments for the idiopathic inflammatory myopathies.
Targeted treatments: To assess the effects (benefits and harms) of targeted immunosuppressant and immunomodulatory treatments for the idiopathic inflammatory myopathies: dermatomyositis (DM, including juvenile dermatomyositis, jDM), immune mediated necrotising myopathy (IMNM), anti-synthetase syndrome (ASS), overlap-myositis (OM) and polymyositis (PM). We will also include cancer-related myositis and amyopathic dermatomyositis.
Non-targeted treatments: To assess the effects (benefits and harms) of non-targeted immunosuppressant and immunomodulatory treatments for the idiopathic inflammatory myopathies: dermatomyositis (DM, including juvenile dermatomyositis, jDM), immune mediated necrotising myopathy (IMNM), anti-synthetase syndrome (ASS), overlap-myositis (OM) and polymyositis (PM). We will also include cancer-related myositis and amyopathic dermatomyositis.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 205.7KB, Terms of use)
-
- Publisher copy:
- 10.1002/14651858.CD014510
Authors
- Publisher:
- Cochrane Collaboration
- Journal:
- Cochrane Database of Systematic Reviews More from this journal
- Volume:
- 2023
- Issue:
- 1
- Article number:
- CD014510
- Publication date:
- 2023-01-30
- DOI:
- EISSN:
-
1465-1858
- Language:
-
English
- Keywords:
- Subtype:
-
Review
- Pubs id:
-
1569915
- Local pid:
-
pubs:1569915
- Deposit date:
-
2023-11-23
Terms of use
- Copyright holder:
- The Cochrane Collaboration
- Copyright date:
- 2023
- Rights statement:
- © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
If you are the owner of this record, you can report an update to it here: Report update to this record